Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients

NCT00190242 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

99

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: group1
DRUG: group2

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]